[Compliance with drivers of the HEARTS-based integrated model for noncommunicable disease control in PeruNível de implementação dos fatores impulsionadores do modelo integrado para doenças não transmissíveis da iniciativa HEARTS no Peru].
To describe compliance with the interventions defined as drivers of the HEARTS-based integrated model for noncommunicable disease control in Peru.
All Ministry of Health institutional health service providers (IHSPs) that are implementing the HEARTS initiative were invited to participate. The assessment was conducted between January and May 2025. Compliance was measured using the maturity index (MI), scored on a five-level scale ranging from incipient to fully mature. The percentage of IHSPs meeting the intervention targets for drivers of the MI for hypertension (HTN), type 2 diabetes mellitus (T2DM), and chronic kidney disease (CKD) was calculated.
Of 1000 IHSPs implementing the model, 92% reported their MIs for HTN, 92% for T2DM, and 93% for CKD. Overall, 82.3% of facilities were at maturity level 1 for HTN, 75% were at level 1 for T2DM, and 99.5% were at level 1 for CKD. For HTN, the target with the highest level of compliance was immediate initiation of pharmacological therapy, achieved by 75% of IHSPs. For T2DM, the targets most frequently met were timely delivery of screening results and early treatment optimization, achieved by 49% of IHSPs. For CKD, the target with the highest level of compliance was availability of a standardized treatment protocol, achieved by 17% of IHSPs.
Although most IHSPs were only at the incipient maturity level, compliance was achieved for some interventions. Priority activities to improve care were identified.
All Ministry of Health institutional health service providers (IHSPs) that are implementing the HEARTS initiative were invited to participate. The assessment was conducted between January and May 2025. Compliance was measured using the maturity index (MI), scored on a five-level scale ranging from incipient to fully mature. The percentage of IHSPs meeting the intervention targets for drivers of the MI for hypertension (HTN), type 2 diabetes mellitus (T2DM), and chronic kidney disease (CKD) was calculated.
Of 1000 IHSPs implementing the model, 92% reported their MIs for HTN, 92% for T2DM, and 93% for CKD. Overall, 82.3% of facilities were at maturity level 1 for HTN, 75% were at level 1 for T2DM, and 99.5% were at level 1 for CKD. For HTN, the target with the highest level of compliance was immediate initiation of pharmacological therapy, achieved by 75% of IHSPs. For T2DM, the targets most frequently met were timely delivery of screening results and early treatment optimization, achieved by 49% of IHSPs. For CKD, the target with the highest level of compliance was availability of a standardized treatment protocol, achieved by 17% of IHSPs.
Although most IHSPs were only at the incipient maturity level, compliance was achieved for some interventions. Priority activities to improve care were identified.
Authors
Benites-Zapata Benites-Zapata, Kikushima-Alcántara Kikushima-Alcántara, Díaz-Arocutipa Díaz-Arocutipa, Herrera-Añazco Herrera-Añazco
View on Pubmed